Apostolaki-Hansson T, et al. - Researchers compared intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOAC) vs with vitamin-K antagonists (VKA) in terms of 90-day survival and functional outcome using data from the Swedish Stroke Register (Riksstroke). After analysis of 2,483 patients (300 with NOAC-ICH and 2,183 with VKA-ICH) was done, no significant difference in mortality and functional outcome at 90 days was seen between NOAC-ICH vs VKA-ICH. Increased age and reduced level of consciousness were the factors that predicted death.